{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T19:48:59Z","timestamp":1785527339984,"version":"3.56.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Racial and Ethnic Health Disparities"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Although interventions have been implemented to reduce long hospital wait times in the United States, this issue persists, particularly among people with sickle cell disease (SCD), a condition that disproportionately affects non-Hispanic Black individuals. It remains unclear whether this persistence is due to a lack of variety of implemented interventions or limitations in the scope of existing programs. Therefore, this scoping review aims to examine published approaches and strategies related to improving the timeliness of care for people with SCD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This scoping review was guided by the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for scoping reviews and the Arksey and O\u2019Malley methodological framework. The Embase, PubMed, Ovid MEDLINE, and CINAHL\n                      <jats:bold>\/<\/jats:bold>\n                      EBSCO databases were searched for peer-reviewed articles published from database inception to February 20, 2026. Included were articles published in English that mentioned approaches to improve long wait times among people with SCD in the United States.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>\n                      Following screening, fifteen articles were identified. Strategies included education (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20092), wait-time guidelines\/protocols (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20097), electronic systems (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20095), specialty sickle cell infusion centers (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20093), and staff communication (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091). Among studies that evaluated interventions, effectiveness was the common outcome of interest, and some of the interventions were found to be ineffective. No approach explicitly employed behavioral or social science theories. None explicitly addressed racial bias or inequitable emergency department care experiences. Also, most were hospital-based and strategies reflected traditional approaches commonly used for hospital-centered programs.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interpretation<\/jats:title>\n                    <jats:p>Overall, additional and more robust strategies are needed to improve hospital wait times for people with SCD. This review identified gaps in knowledge that, if addressed, may help guide continued innovation in the design of interventions to improve long wait times for people with SCD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s40615-026-03113-9","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T19:22:50Z","timestamp":1785266570000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Published Approaches to Improving Timeliness of Care for People with Sickle Cell Disease in the United States: A Scoping Review"],"prefix":"10.1007","author":[{"given":"Olufunke","family":"Akiyode","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana S.","family":"Agboh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaliyah S.","family":"Butts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara J.","family":"Manning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7335-8597","authenticated-orcid":false,"given":"Chinenye Lynette","family":"Ejezie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"3113_CR1","unstructured":"U.S. Department of Health and Human Services Expert Panel Report. 2014. Evidence-Based Management of Sickle Cell Disease https:\/\/www.nhlbi.nih.gov\/sites\/default\/files\/media\/docs\/sickle-cell-disease-report%20020816_0.pdf Accessed April 4, 2026."},{"issue":"1","key":"3113_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.focus.2023.100158","volume":"3","author":"BK Attell","year":"1999","unstructured":"Attell BK, Barrett PM, Pace BS, McLemore ML, McGee BT, Oshe R, et al. Characteristics of emergency department visits made by individuals with sickle cell disease in the US, 1999\u20132020. AJPM Focus. 1999;3(1):100158.","journal-title":"AJPM Focus"},{"issue":"2","key":"3113_CR3","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/CNQ.0000000000000350","volume":"44","author":"N Crego","year":"2021","unstructured":"Crego N, Masese R, Bonnabeau E, Douglas C, Rains G, Shah N, et al. Patient perspectives of sickle cell management in the emergency department. Crit Care Nurs Q. 2021;44(2):160\u201374.","journal-title":"Crit Care Nurs Q"},{"issue":"1","key":"3113_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-019-4726-5","volume":"19","author":"A Renedo","year":"2019","unstructured":"Renedo A, Miles S, Chakravorty S, Leigh A, Telfer P, Warner JO, et al. Not being heard: barriers to high quality unplanned hospital care during young people\u2019s transition to adult services\u2013evidence from \u2018this sickle cell life\u2019research. BMC Health Serv Res. 2019;19(1):876.","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"3113_CR5","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.ajem.2012.11.005","volume":"31","author":"C Haywood Jr","year":"2013","unstructured":"Haywood C Jr, Tanabe P, Naik R, Beach MC, Lanzkron S. The impact of race and disease on sickle cell patient wait times in the emergency department. Am J Emerg Med. 2013;31(4):651\u20136.","journal-title":"Am J Emerg Med"},{"key":"3113_CR6","doi-asserted-by":"publisher","first-page":"7530","DOI":"10.1182\/blood-2024-207564","volume":"144","author":"JB Mendoza","year":"2024","unstructured":"Mendoza JB, Albright C, Seastrand K, Seedhouse K, Young R, Bryson M, et al. Time is quality of life (QoL): an institutional review of emergency department management of acute vaso-occlusive episodes in patients with sickle cell disease. Blood. 2024;144:7530.","journal-title":"Blood"},{"key":"3113_CR7","volume":"6","author":"KF Alrasheedi","year":"2019","unstructured":"Alrasheedi KF, Al-Mohaithef M, Edrees HH, Chandramohan S. The association between wait times and patient satisfaction: findings from primary health centers in the Kingdom of Saudi Arabia. Health Serv Res Manag Epidemiol. 2019;6:2333392819861246.","journal-title":"Health Serv Res Manag Epidemiol"},{"issue":"3","key":"3113_CR8","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s11606-014-3089-1","volume":"30","author":"JM Taber","year":"2015","unstructured":"Taber JM, Leyva B, Persoskie A. Why do people avoid medical care? A qualitative study using national data. J Gen Intern Med. 2015;30(3):290\u20137.","journal-title":"J Gen Intern Med"},{"key":"3113_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.socscimed.2012.12.020","volume":"82","author":"AN Polonijo","year":"2013","unstructured":"Polonijo AN, Carpiano RM. Social inequalities in adolescent human papillomavirus (HPV) vaccination: a test of fundamental cause theory. Social science & medicine (1982). 2013;82:115\u201325.","journal-title":"Social science & medicine (1982)"},{"key":"3113_CR10","doi-asserted-by":"crossref","unstructured":"Link BG, Phelan J. Social conditions as fundamental causes of disease. J health social Behav 1995 Jan 1:80\u201394.","DOI":"10.2307\/2626958"},{"issue":"4","key":"3113_CR11","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1037\/hea0000242","volume":"35","author":"DR Williams","year":"2016","unstructured":"Williams DR, Priest N, Anderson NB. Understanding associations among race, socioeconomic status, and health: Patterns and prospects. Health Psychol. 2016;35(4):407.","journal-title":"Health Psychol"},{"issue":"7","key":"3113_CR12","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467\u201373.","journal-title":"Ann Intern Med"},{"issue":"1","key":"3113_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/1364557032000119616","volume":"8","author":"H Arksey","year":"2005","unstructured":"Arksey H, O\u2019malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19\u201332.","journal-title":"Int J Soc Res Methodol"},{"issue":"1","key":"3113_CR14","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan\u2014a web and mobile app for systematic reviews. Syst reviews. 2016;5(1):210.","journal-title":"Syst reviews"},{"issue":"3","key":"3113_CR15","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jemermed.2014.09.009","volume":"48","author":"PA Patrick","year":"2015","unstructured":"Patrick PA, Rosenthal BM, Iezzi CA, Brand DA. Timely pain management in the emergency department. J Emerg Med. 2015;48(3):267\u201373. https:\/\/doi.org\/10.1016\/j.jemermed.2014.09.009.","journal-title":"J Emerg Med"},{"issue":"6","key":"3113_CR16","doi-asserted-by":"publisher","first-page":"399","DOI":"10.2217\/cer-2021-0257","volume":"11","author":"R Skinner","year":"2022","unstructured":"Skinner R, Breck A, Esposito D. An impact evaluation of two modes of care for sickle cell disease crises. J Comp Eff Res. 2022;11(6):399\u2013409. https:\/\/doi.org\/10.2217\/cer-2021-0257.","journal-title":"J Comp Eff Res"},{"issue":"11","key":"3113_CR17","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1001\/jamapediatrics.2025.2967","volume":"179","author":"I Gwarzo","year":"2025","unstructured":"Gwarzo I, Coleman KD, McKinley K, et al. Opioid Timeliness in the Emergency Department and Hospitalizations for Acute Sickle Cell Pain. JAMA Pediatr. 2025;179(11):1194\u2013202. https:\/\/doi.org\/10.1001\/jamapediatrics.2025.2967.","journal-title":"JAMA Pediatr"},{"issue":"3S","key":"3113_CR18","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1016\/j.annemergmed.2020.08.008","volume":"76","author":"S Della-Moretta","year":"2020","unstructured":"Della-Moretta S, Delatore L, Purcell M, et al. The effect of use of individualized pain plans in sickle cell patients presenting to the emergency department. Ann Emerg Med. 2020;76(3S):S21\u20137. https:\/\/doi.org\/10.1016\/j.annemergmed.2020.08.008.","journal-title":"Ann Emerg Med"},{"issue":"5","key":"3113_CR19","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/ajh.23961","volume":"90","author":"S Lanzkron","year":"2015","unstructured":"Lanzkron S, Carroll CP, Hill P, David M, Paul N, Haywood C Jr. Impact of a dedicated infusion clinic for acute management of adults with sickle cell pain crisis. Am J Hematol. 2015;90(5):376\u201380. https:\/\/doi.org\/10.1002\/ajh.23961.","journal-title":"Am J Hematol"},{"issue":"12","key":"3113_CR20","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1093\/pm\/pnac096","volume":"23","author":"AA Wachnik","year":"2022","unstructured":"Wachnik AA, Welch-Coltrane JL, Adams MCB, et al. A standardized emergency department order set decreases admission rates and in-patient length of stay for adults patients with sickle cell disease. Pain Med. 2022;23(12):2050\u201360. https:\/\/doi.org\/10.1093\/pm\/pnac096.","journal-title":"Pain Med"},{"issue":"9","key":"3113_CR21","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.7326\/M20-7171","volume":"174","author":"S Lanzkron","year":"2021","unstructured":"Lanzkron S, Little J, Wang H, et al. Treatment of acute pain in adults with sickle cell disease in an infusion center versus the emergency department: a multicenter prospective cohort study. Ann Intern Med. 2021;174(9):1207\u201313. https:\/\/doi.org\/10.7326\/M20-7171.","journal-title":"Ann Intern Med"},{"issue":"5","key":"3113_CR22","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1080\/03630269.2016.1232272","volume":"40","author":"D Pulte","year":"2016","unstructured":"Pulte D, Lovett PB, Axelrod D, Crawford A, McAna J, Powell R. Comparison of emergency department wait times in adults with sickle cell disease versus other painful etiologies. Hemoglobin. 2016;40(5):330\u20134. https:\/\/doi.org\/10.1080\/03630269.2016.1232272.","journal-title":"Hemoglobin"},{"issue":"23","key":"3113_CR23","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.1182\/bloodadvances.202501653","volume":"9","author":"A Abu Haimed","year":"2025","unstructured":"Abu Haimed A, Patel D, Clopton O, et al. Use of Emergency Severity Index 2 reduces time to first analgesia in sickle cell disease vaso-occlusive crisis. Blood Adv. 2025;9(23):6199\u2013204. https:\/\/doi.org\/10.1182\/bloodadvances.202501653.","journal-title":"Blood Adv"},{"issue":"5","key":"3113_CR24","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.jen.2021.05.00","volume":"47","author":"E Linton","year":"2021","unstructured":"Linton E, Souffront K, Gordon L, Loo GT, Genes N, Glassberg J. System Level Informatics to Improve Triage Practices for Sickle Cell Disease Vaso-Occlusive Crisis: A Cluster Randomized Controlled Trial. J Emerg Nurs. 2021;47(5):742\u2013e7511. https:\/\/doi.org\/10.1016\/j.jen.2021.05.00.","journal-title":"J Emerg Nurs"},{"issue":"3S","key":"3113_CR25","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1016\/j.annemergmed.2020.08.00","volume":"76","author":"DC Brousseau","year":"2020","unstructured":"Brousseau DC, Alpern ER, Chamberlain JM, et al. A Multiyear Cross-sectional Study of Guideline Adherence for the Timeliness of Opioid Administration in Children With Sickle Cell Pain Crisis. Ann Emerg Med. 2020;76(3S):S6\u201311. https:\/\/doi.org\/10.1016\/j.annemergmed.2020.08.00.","journal-title":"Ann Emerg Med"},{"issue":"3","key":"3113_CR26","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jcjq.2016.12.005","volume":"43","author":"P Tanabe","year":"2017","unstructured":"Tanabe P, Freiermuth CE, Cline DM, Silva S. A Prospective Emergency Department Quality Improvement Project to Improve the Treatment of Vaso-Occlusive Crisis in Sickle Cell Disease: Lessons Learned. Jt Comm J Qual Patient Saf. 2017;43(3):116\u201326. https:\/\/doi.org\/10.1016\/j.jcjq.2016.12.005.","journal-title":"Jt Comm J Qual Patient Saf"},{"issue":"3","key":"3113_CR27","doi-asserted-by":"publisher","DOI":"10.1097\/pq9.0000000000000821","volume":"10","author":"AF Wong","year":"2025","unstructured":"Wong AF, Otillio JK, Fahnestock AK, et al. Reducing time to analgesia for sickle cell pain episode treatment in the pediatric emergency department. Pediatr Qual Saf. 2025;10(3):e821. https:\/\/doi.org\/10.1097\/pq9.0000000000000821.","journal-title":"Pediatr Qual Saf"},{"issue":"9","key":"3113_CR28","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.29569","volume":"14","author":"T Arnold","year":"2022","unstructured":"Arnold T, Coffee RL Jr, Rosenberg L, et al. A quality improvement initiative to decrease time to analgesia in patients with sickle cell and vaso-occlusive crisis: a population with disparities in treatment. Cureus. 2022;14(9):e29569. https:\/\/doi.org\/10.7759\/cureus.29569.","journal-title":"Cureus"},{"issue":"2","key":"3113_CR29","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.jen.2025.11.007","volume":"52","author":"B Daniels","year":"2026","unstructured":"Daniels B, Hughes MV, Ludwig-Beymer P, Houchins T, Burke M. Decreasing door-to-analgesia time: increasing use of sickle cell pain management pathway. J Emerg Nurs. 2026;52(2):313\u201325. https:\/\/doi.org\/10.1016\/j.jen.2025.11.007.","journal-title":"J Emerg Nurs"},{"key":"3113_CR30","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1111\/j.1752-7325.2011.00223.x","volume":"71","author":"LK Bartholomew","year":"2011","unstructured":"Bartholomew LK, Mullen PD. Five roles for using theory and evidence in the design and testing of behavior change interventions. J Public Health Dent. 2011;71:S20\u201333.","journal-title":"J Public Health Dent"},{"issue":"4","key":"3113_CR31","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/jep.13720","volume":"29","author":"R Harrison","year":"2022","unstructured":"Harrison R, Sh\u00e9 \u00c9N, Debono D, Chauhan A, Newman B. Creating space for theory when codesigning healthcare interventions. J Eval Clin Pract. 2022;29(4):572.","journal-title":"J Eval Clin Pract"},{"key":"3113_CR32","volume-title":"Birth prevalence of sickle cell disease and county-level social vulnerability\u2014sickle cell data collection program, 11 states, 2016\u20132020","author":"M Kayle","year":"2024","unstructured":"Kayle M. Birth prevalence of sickle cell disease and county-level social vulnerability\u2014sickle cell data collection program, 11 states, 2016\u20132020. Volume 73. Morbidity and mortality weekly report: MMWR; 2024."},{"issue":"3","key":"3113_CR33","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/gim.2012.128","volume":"15","author":"Y Wang","year":"2013","unstructured":"Wang Y, Kennedy J, Caggana M, Zimmerman R, Thomas S, Berninger J, et al. Sickle cell disease incidence among newborns in New York State by maternal race\/ethnicity and nativity. Genet Med. 2013;15(3):222\u20138.","journal-title":"Genet Med"}],"container-title":["Journal of Racial and Ethnic Health Disparities"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-026-03113-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40615-026-03113-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-026-03113-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:11:37Z","timestamp":1785521497000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40615-026-03113-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":33,"alternative-id":["3113"],"URL":"https:\/\/doi.org\/10.1007\/s40615-026-03113-9","relation":{},"ISSN":["2197-3792","2196-8837"],"issn-type":[{"value":"2197-3792","type":"print"},{"value":"2196-8837","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"assertion":[{"value":"24 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors agreed to the publication of this manuscript.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None used.","order":4,"name":"Ethics","label":"Use of AI","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"NA.","order":5,"name":"Ethics","label":"Clinical Trial Number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"NA.","order":6,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}